Literature DB >> 10781613

Cloning and expression of a novel MAPKK-like protein kinase, lymphokine-activated killer T-cell-originated protein kinase, specifically expressed in the testis and activated lymphoid cells.

Y Abe1, S Matsumoto, K Kito, N Ueda.   

Abstract

A novel protein kinase, TOPK (T-LAK cell-originated protein kinase), was isolated from a lymphokine-activated killer T (T-LAK) cell subtraction cDNA fragment library. The open reading frame of the TOPK gene encodes a protein of 322 amino acids, possessing a protein kinase domain profile. The cap site analysis of the 5'-end of TOPK mRNA revealed two forms, a major full-length form and a minor spliced form at the 5'-site, both encoding the same protein. A BLAST homology search and phylogenetic analysis indicated that TOPK is related to dual specific mitogen-activated protein kinase kinase (MAPKK). The transfection of the TOPK gene to COS-7 cells up-regulated a phosphorylation of p38 MAPK but not ERK1/2 or SAPK/JNK. Gel precipitation study indicated that TOPK protein can be associated with p38 in vitro. Tissue distribution of TOPK mRNA expression was specific for the testis, T-LAK cells, activated lymphoid cells, and lymphoid tumors. On the other hand, deactivated T-LAK cells did not show TOPK mRNA expression. These data suggest that TOPK is a newly identified member of a novel MEK3/6-related MAPKK that may be enrolled in the activation of lymphoid cells and support testicular functions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10781613     DOI: 10.1074/jbc.M909629199

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  66 in total

1.  A global genomic view on LNX siRNA-mediated cell cycle arrest.

Authors:  Dan Zheng; Shaohua Gu; Yao Li; Chaoneng Ji; Yi Xie; Yumin Mao
Journal:  Mol Biol Rep       Date:  2010-11-21       Impact factor: 2.316

2.  Interleukin-6 and its receptor, key players in hepatobiliary inflammation and cancer.

Authors:  Christopher Johnson; Yuyan Han; Nathan Hughart; Jennifer McCarra; Gianfranco Alpini; Fanyin Meng
Journal:  Transl Gastrointest Cancer       Date:  2012-04-01

3.  T-LAK cell-originated protein kinase (TOPK) phosphorylation of Prx1 at Ser-32 prevents UVB-induced apoptosis in RPMI7951 melanoma cells through the regulation of Prx1 peroxidase activity.

Authors:  Tatyana A Zykova; Feng Zhu; Tatyana I Vakorina; Jishuai Zhang; Lee Ann Higgins; Darya V Urusova; Ann M Bode; Zigang Dong
Journal:  J Biol Chem       Date:  2010-07-20       Impact factor: 5.157

4.  PBK as a Potential Biomarker Associated with Prognosis of Glioblastoma.

Authors:  Chengyuan Dong; Wenhua Fan; Sheng Fang
Journal:  J Mol Neurosci       Date:  2019-10-15       Impact factor: 3.444

5.  Umbelliferone Alleviates Myocardial Ischemia: the Role of Inflammation and Apoptosis.

Authors:  Jianxiang Gan; Weichun Qian; Song Lin
Journal:  Inflammation       Date:  2018-03       Impact factor: 4.092

6.  CDK1-mediated mitotic phosphorylation of PBK is involved in cytokinesis and inhibits its oncogenic activity.

Authors:  Seth Stauffer; Yongji Zeng; Jiuli Zhou; Xingcheng Chen; Yuanhong Chen; Jixin Dong
Journal:  Cell Signal       Date:  2017-08-03       Impact factor: 4.315

7.  Phosphorylation of IκBα at serine 32 by T-lymphokine-activated killer cell-originated protein kinase is essential for chemoresistance against doxorubicin in cervical cancer cells.

Authors:  Jung-Hwan Park; Dae-Sung Yoon; Hye-Jin Choi; Dae-Hyun Hahm; Sang-Muk Oh
Journal:  J Biol Chem       Date:  2012-12-17       Impact factor: 5.157

8.  [18F]FE-OTS964: a Small Molecule Targeting TOPK for In Vivo PET Imaging in a Glioblastoma Xenograft Model.

Authors:  Giacomo Pirovano; Sheryl Roberts; Christian Brand; Patrick L Donabedian; Christian Mason; Paula Demétrio de Souza; Geoff S Higgins; Thomas Reiner
Journal:  Mol Imaging Biol       Date:  2019-08       Impact factor: 3.488

9.  Stable interference of EWS-FLI1 in an Ewing sarcoma cell line impairs IGF-1/IGF-1R signalling and reveals TOPK as a new target.

Authors:  D Herrero-Martín; D Osuna; J L Ordóñez; V Sevillano; A S Martins; C Mackintosh; M Campos; J Madoz-Gúrpide; A P Otero-Motta; G Caballero; A T Amaral; D H Wai; Y Braun; M Eisenacher; K-L Schaefer; C Poremba; E de Alava
Journal:  Br J Cancer       Date:  2009-06-02       Impact factor: 7.640

10.  Prognostic and predictive value of TOPK stratified by KRAS and BRAF gene alterations in sporadic, hereditary and metastatic colorectal cancer patients.

Authors:  I Zlobec; F Molinari; M Kovac; M P Bihl; H J Altermatt; J Diebold; H Frick; M Germer; M Horcic; M Montani; G Singer; H Yurtsever; A Zettl; L Terracciano; L Mazzucchelli; P Saletti; M Frattini; K Heinimann; A Lugli
Journal:  Br J Cancer       Date:  2009-11-24       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.